EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Dynamics-Guided Triage of Approved Drugs Against Escherichia coli Resistance Targets Nominates Capmatinib, Metergoline and Nilotinib as Candidates for Experimental Testing

Mena Abdelsayed, Yassir Boulaamane iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27209017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Mena Abdelsayed und 1 weiteren Autor:innen. Beteiligte Einrichtung: Lankenau Institute for Medical Research, Philadelphia, PA 19096, USA. Hauptthemen laut MEDLINE: Pyrimidines, Escherichia coli, Molecular Dynamics Simulation, Triazines. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Virtual screening ranks compounds by scoring functions that correlate with molecular size, and hit lists are rarely benchmarked against compounds of established activity. We screened 2070 approved drugs against four Escherichia coli targets selected by pocket-druggability triage (FabI, LpxC, DHFR and GyrB), with each docking protocol validated by redocking its native ligand (RMSD 0.50–0.69 Å). Per target, the two top-scoring compounds and a reference inhibitor were simulated for 100 ns in triplicate (12 complexes, 3.6 μs). Docking did not recover the references: trimethoprim ranked 762/2068 and novobiocin 576/2069, while top-ranked compounds were large, promiscuous drugs recurring across unrelated targets. Pose triage failed, too: all twelve complexes retained 43–87% of initial contacts, contact-loss time separated targets, not compounds, and MM-GBSA favoured the reference at one target of four. Persistent hydrogen bonding separated the reference from the hits at three of four targets, by 2–9-fold, although the GyrB result rests largely on one replicate. Benchmarking each hit against its reference nominates three candidates for experimental testing: capmatinib at DHFR, metergoline at FabI and nilotinib at LpxC. Capmatinib ranks highest on these computational criteria, with the highest pocket retention (87%) and an MM-GBSA energy with no detectable difference from trimethoprim’s at n = 3 (absence of evidence for a difference, not evidence of equivalence). In this small panel, carrying a known active through the same pipeline was therefore more informative than docking score, pose stability or end-point rescoring. The nominations are hypotheses: no experimental validation was performed, and generality would require multiple actives and property-matched decoys per target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesEscherichia coliMolecular Dynamics SimulationTriazinesAnti-Bacterial AgentsDrug Resistance, BacterialImidazolesMolecular Docking SimulationTetrahydrofolate DehydrogenaseEscherichia coli ProteinsLigands

Stichwörter der Autor:innen

FabILpxCantimicrobial resistancecapmatinibdihydrofolate reductasedrug repurposinghydrogen bondingmolecular dockingmolecular dynamicsscoring-function bias

Substanzen

PyrimidinesnilotinibTriazinesAnti-Bacterial AgentsTetrahydrofolate DehydrogenaseEscherichia coli ProteinsLigandsImidazoles

Autor:innen und Institutionen

  • Lankenau Institute for Medical Research, Philadelphia, PA 19096, USA.
  • Laboratory of Innovative Technologies, National School of Applied Sciences of Tangier, Abdelmalek Essaadi University, Tetouan 93000, Morocco.

ORCID-Profile: Yassir Boulaamane

Zitieren

APA

Abdelsayed, M., & Boulaamane, Y. (2026). Molecular Dynamics-Guided Triage of Approved Drugs Against Escherichia coli Resistance Targets Nominates Capmatinib, Metergoline and Nilotinib as Candidates for Experimental Testing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209017

Vancouver

Abdelsayed M, Boulaamane Y. Molecular Dynamics-Guided Triage of Approved Drugs Against Escherichia coli Resistance Targets Nominates Capmatinib, Metergoline and Nilotinib as Candidates for Experimental Testing. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209017

BibTeX
@article{Abdelsayed2026,
  author = {Abdelsayed, Mena and Boulaamane, Yassir},
  title = {Molecular Dynamics-Guided Triage of Approved Drugs Against Escherichia coli Resistance Targets Nominates Capmatinib, Metergoline and Nilotinib as Candidates for Experimental Testing},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27209017}
}
Kostenlos starten →